Factors Affecting Dissemination Events Early in Bubonic Plague
影响黑死病早期传播事件的因素
基本信息
- 批准号:8605167
- 负责人:
- 金额:$ 22.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-01-15 至 2015-12-31
- 项目状态:已结题
- 来源:
- 关键词:AerosolsAffectAntigensAppearanceArthropodsBacteriaBeliefBiological AssayBioterrorismBiteBubonic PlagueCellsCessation of lifeCountryDataDefectDevelopmentDiseaseDisease ProgressionEmerging Communicable DiseasesEventFleasFlow CytometryGenesGeneticGoalsHumanImmunosuppressionIn VitroIncidenceInfectionInfection ControlLeadLymphatic SystemMammalsModelingMonitorMutationNatureOligonucleotidesOrganismOutcomePathogenesisPatientsPhagocytesPhagocytosisPlaguePopulationProcessRecording of previous eventsReportingRouteShapesSiteStagingStaining methodStainsSurveysTestingTherapeuticTimeTissuesType III Secretion System PathwayVaccinesVirulenceVirulence FactorsYersinia pestisanimal ecologybasecapsulecell typeextracellularfeedinghuman ecologyin vivoinsightlymph nodesmortalitymutantpandemic diseasepathogenpathogenic bacteriaprophylacticpublic health relevanceresponsetherapeutic targettrafficking
项目摘要
DESCRIPTION (provided by applicant): Yersinia pestis is the causative agent of disease in a variety of mammals, and humans can become infected when human and animal ecologies intersect. This has led to several pandemics of plague in human history, and infection with Y. pestis is currently considered by the WHO as a re-emerging infectious disease because of the increased incidence in a wide number of countries. Bubonic plague is the most common form of disease and the untreated mortality rate is estimated at 40-70%.
A number of recent studies from several groups suggest that Y. pestis actively causes immunosuppression early during infection. Furthermore, recent studies have shown that very early events after inoculation are responsible for determining the outcome of infection. One of the first steps in the pathogenesis of bubonic plague is dissemination of the pathogen from the inoculation site (IS) to the draining lymph node (DLN). It has long been believed that the bacteria disseminate to the DLN by trafficking in phagocytic cells. However, there is strikingly little in vivo data demonstrating this. We hypothesize that Y. pestis actively influences these early dissemination events by interacting with key components of the host innate response. Our long-term goal is to understand the mechanism of dissemination of Y. pestis from the IS to the DLN. Using an intradermal route (the route that most closely mimics that of the flea) of inoculation and a dissemination assay we recently developed, we are able to monitor the transit of bacteria to the DLN from the IS, and subsequently to systemic tissues. Here, we will specifically test in vivo (a) the widely held belief that phagocytic cells are important for traffiking Y. pestis from the IS to the DLN, and (b) effects by the Y. pestis virulence factors known to affect interactions with phagocytic cells in vitro for their impact on early dissemination to the DLN.
描述(由申请人提供):耶尔森氏菌是多种哺乳动物中疾病的病因,当人类和动物生态相交时,人类可能会被感染。这导致了人类历史上的几种大瘟疫大流行病,由于广泛的国家发生的发病率增加,WHO目前将WHO视为一种重新出现的传染病。泡沫瘟疫是最常见的疾病形式,未处理的死亡率估计为40-70%。
来自几个小组的许多最新研究表明,柴杆菌在感染期间早期积极引起免疫抑制。此外,最近的研究表明,接种后非常早期的事件负责确定感染的结果。泡沫瘟疫发病机理的第一步之一是将病原体从接种部位(IS)传播到排水淋巴结(DLN)。长期以来,人们一直认为,细菌通过在吞噬细胞中运输将其传播到DLN。但是,体内数据很少有证明这一点。我们假设Y. Pestis通过与宿主先天反应的关键组成部分互动来积极影响这些早期传播事件。我们的长期目标是了解从IS到DLN传播Y. Pestis的机制。使用接种的接种途径(最紧密地模拟跳蚤的途径)和我们最近开发的传播测定法,我们能够监测细菌从IS到DLN的转运,然后从IS,然后是全身组织。在这里,我们将在体内特异性测试(a)广泛持有的信念,即吞噬细胞对从IS到DLN的鼠疫pestis很重要,以及(b)pestis毒力因素已知会影响与吞噬细胞相互作用的Y. pestis毒力因子的作用细胞在体外对早期传播到DLN的影响。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VIRGINIA L MILLER其他文献
VIRGINIA L MILLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VIRGINIA L MILLER', 18)}}的其他基金
Understanding hypermucoviscosity in Klebsiella
了解克雷伯氏菌的高粘膜粘稠度
- 批准号:
10442731 - 财政年份:2020
- 资助金额:
$ 22.62万 - 项目类别:
Understanding hypermucoviscosity in Klebsiella
了解克雷伯氏菌的高粘膜粘稠度
- 批准号:
10217978 - 财政年份:2020
- 资助金额:
$ 22.62万 - 项目类别:
Understanding hypermucoviscosity in Klebsiella
了解克雷伯氏菌的高粘膜粘稠度
- 批准号:
10651812 - 财政年份:2020
- 资助金额:
$ 22.62万 - 项目类别:
2016 Microbial Toxins & Pathogenicity Gordon Research Conferences and Gordon Research Seminar
2016年微生物毒素
- 批准号:
9120487 - 财政年份:2016
- 资助金额:
$ 22.62万 - 项目类别:
Factors Affecting Dissemination Events Early in Bubonic Plague
影响黑死病早期传播事件的因素
- 批准号:
8485851 - 财政年份:2013
- 资助金额:
$ 22.62万 - 项目类别:
Yessinia autotransporters (Yaps): Structure, function, and host response
Yessinia 自转运蛋白 (Yaps):结构、功能和宿主响应
- 批准号:
8375890 - 财政年份:2012
- 资助金额:
$ 22.62万 - 项目类别:
Yessinia autotransporters (Yaps): Structure, function, and host response
Yessinia 自转运蛋白 (Yaps):结构、功能和宿主响应
- 批准号:
8234194 - 财政年份:2011
- 资助金额:
$ 22.62万 - 项目类别:
相似国自然基金
E3泛素连接酶MDM2对乙肝表面抗原组装和分泌的影响及机制研究
- 批准号:82300690
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
甲型流感病毒H1N1变异对抗原性和感染性的影响机制研究
- 批准号:82372225
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
幽门螺杆菌O-抗原连接酶WaaL通过调控IV型分泌系统的组装影响其致病性的机制研究
- 批准号:82300649
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ATP6V0C通过调控溶酶体功能影响泡沫细胞抗原提呈能力致麻风菌免疫逃逸的机制研究
- 批准号:82273545
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
新型H5亚型禽流感病毒变异对抗原性影响及其分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
Design and development of a novel, thermostable, and inhalable dry powder COVID-19 vaccine
新型热稳定性可吸入干粉 COVID-19 疫苗的设计和开发
- 批准号:
10611975 - 财政年份:2022
- 资助金额:
$ 22.62万 - 项目类别:
Design and development of a novel, thermostable, and inhalable dry powder COVID-19 vaccine
新型热稳定性可吸入干粉 COVID-19 疫苗的设计和开发
- 批准号:
10333095 - 财政年份:2022
- 资助金额:
$ 22.62万 - 项目类别:
Human Monoclonal Antibodies for Encephalitic Alphaviruses
脑炎甲病毒的人单克隆抗体
- 批准号:
10669266 - 财政年份:2022
- 资助金额:
$ 22.62万 - 项目类别:
Electrosprayed Core-Shell Microparticles as a Pulsatile Vaccine Delivery Platform
电喷雾核壳微粒作为脉冲疫苗输送平台
- 批准号:
10195135 - 财政年份:2021
- 资助金额:
$ 22.62万 - 项目类别:
Development of a novel TB vaccine safer and more effective than BCG based on a precisely controlled replication-limited Mycobacterium tuberculosis engineered for optimal in vivo growth and clearance
基于精确控制的复制限制结核分枝杆菌,开发出比卡介苗更安全、更有效的新型结核疫苗,该疫苗经过精心设计,可实现最佳的体内生长和清除
- 批准号:
10115911 - 财政年份:2021
- 资助金额:
$ 22.62万 - 项目类别: